Filtros de búsqueda

Lista de obras de

1,2,4-triazolo[1,5-a]quinoxaline derivatives and their simplified analogues as adenosine A₃ receptor antagonists. Synthesis, structure-affinity relationships and molecular modeling studies.

artículo científico publicado en 2014

A rare case of prothrombin time prolongation

artículo científico publicado en 2020

Anticoagulation in Italian patients with venous thromboembolism and thrombophilic alterations: findings from START2 register study

artículo científico publicado en 2020

Anticoagulation resumption after intracranial hemorrhage in patients treated with VKA and DOACs

scientific article published on 07 June 2020

Bleeding Risk in Very Old Patients on Vitamin K Antagonist Treatment

scientific article published on 01 August 2011

Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register

scientific article published on 27 November 2020

Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis

scientific article published on May 2011

D-dimer levels during and after anticoagulation withdrawal in patients with venous thromboembolism treated with non-vitamin K anticoagulants

scientific article published on 16 July 2019

D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study

scientific article published on 05 November 2019

Design and rationale of a randomized, placebo-controlled trial on the efficacy and safety of sulodexide for extended treatment in elderly patients after a first venous thromboembolism

scientific article published on 25 May 2020

Gender differences of bleeding and stroke risk in very old atrial fibrillation patients on VKA treatment: results of the EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics).

artículo científico publicado en 2012

Hyperhomocysteinemia and vitamin B6 deficiency: new risk markers for nonvalvular atrial fibrillation?

artículo científico publicado en 2004

Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists. Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics).

artículo científico publicado en 2012

Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism

artículo científico publicado en 2003

Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Event registry

Managing anticoagulation in the COVID-19 era between lockdown and reopening phases

artículo científico publicado en 2020

Mechanical prosthetic heart valves: Quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study

artículo científico publicado en 2018

Oral anticoagulation in very elderly patients with atrial fibrillation: Results from the prospective multicenter START2-REGISTER study.

artículo científico publicado en 2019

Patient-level compared with study-level meta-analyses demonstrate consistency of D-dimer as predictor of venous thromboembolic recurrences

artículo científico publicado en 2013

Patients with isolated pulmonary embolism in comparison to those with deep venous thrombosis. Differences in characteristics and clinical evolution

scientific article published on 07 September 2019

Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention

artículo científico publicado en 2009

Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis

artículo científico publicado en 2011

Risks factors for highly unstable response to oral anticoagulation: a case-control study

artículo científico publicado en 2005

The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation

artículo científico publicado en 2015

The identification of the 2-phenylphthalazin-1(2H)-one scaffold as a new decorable core skeleton for the design of potent and selective human A3 adenosine receptor antagonists

artículo científico publicado en 2011

The negative predictive value of D-dimer on the risk of recurrent venous thromboembolism in patients with multiple previous events: a prospective cohort study (the PROLONG PLUS study).

artículo científico publicado en 2012

Use of D-dimer testing to determine duration of anticoagulation, risk of cardiovascular events and occult cancer after a first episode of idiopathic venous thromboembolism: the extended follow-up of the PROLONG study

artículo científico publicado en 2009

Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study

artículo científico publicado en 2009

Warfarin prescription in patients with nonvalvular atrial fibrillation and one non-gender-related risk factor (CHA2 DS2 VASc 1 or 2): A treatment dilemma

artículo científico publicado en 2017